UK Markets closed

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1900+0.0300 (+2.59%)
At close: 04:00PM EDT
1.1800 -0.01 (-0.84%)
After hours: 07:53PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate-0.41-0.41-1.66-0.85
Low estimate-0.43-0.44-1.69-1.08
High estimate-0.38-0.37-1.64-0.67
Year ago EPS-0.61-0.56-2.27-1.66
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate37.03M39.61M154.81M196.04M
Low estimate35.1M36.5M146.2M151.6M
High estimate39M42M161M246M
Year ago sales36.82MN/A148.76M154.81M
Sales growth (year/est)0.60%N/A4.10%26.60%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.56-0.48-0.57-0.43
Actual EPS-0.61-0.56-0.48-0.44
Difference-0.05-0.080.09-0.01
Surprise %-8.90%-16.70%15.80%-2.30%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.41-0.41-1.66-0.85
7 days ago-0.41-0.41-1.66-0.85
30 days ago-0.41-0.41-1.66-0.83
60 days ago-0.41-0.41-1.66-0.83
90 days ago-0.41-0.4-1.65-0.95
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCLVSIndustrySector(s)S&P 500
Current qtr.32.80%N/AN/AN/A
Next qtr.26.80%N/AN/AN/A
Current year26.90%N/AN/AN/A
Next year48.80%N/AN/AN/A
Next 5 years (per annum)79.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A